BeOne Medicines Ltd.ONC

Market cap

$443.5B

P/E ratio

	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12
Cash and cash equivalents	88	240	741	621	1,390	4,383	3,875	3,186	2,639
Marketable securities, current	561	598	2,137	365	3,269	2,242	-	-	-
Total cash & short-term investments	649	838	2,878	986	4,659	6,625	3,875	3,186	2,639
Accounts receivable, net	-	29	41	71	60	483	173	358	676
Inventories	-	11	16	29	89	243	282	416	495
Total current assets	374	913	1,944	1,173	4,961	7,614	5,207	4,203	3,992
Property, plant and equipment, net	26	63	157	242	358	588	846	1,324	1,578
Total non-current assets	31	133	306	440	640	1,032	1,172	1,602	1,929
Total assets	406	1,046	2,250	1,612	5,601	8,646	6,379	5,805	5,921
Accounts payable	12	70	113	122	232	262	295	315	405
Long-term debt, current	-	9	9	-	-	-	-	-	-
Total current liabilities	35	150	246	310	1,075	1,600	1,469	1,810	2,215
Long-term debt, non-current	-	9	41	83	-	-	-	-	-
Total non-current liabilities	18	212	250	324	656	803	527	458	374
Total liabilities	53	362	496	634	1,732	2,403	1,996	2,268	2,589
Common stock and paid-in capital	591	1,001	2,745	2,926	7,415	11,191	11,541	11,599	12,088
Retained earnings	-237	-331	-1,007	-1,956	-3,553	-4,966	-7,080	-7,962	-8,607
Stockholders' equity	353	684	1,754	978	3,869	6,243	4,383	3,537	3,332
Total debt	-	18	50	580	-	-	-	-	-
Net debt	-	-819	-2,828	-406	-1,275	-2,612	-164	-	-1,621
D/E ratio (%)	-	2.7	2.8	59.3	87.5	64.3	84.7	177.8	30.6
Working capital	-